Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R01DA047236 | U.S. NIH Grant/Contract | View source | |
| K24DA037109 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Miami | OTHER |
| The Miriam Hospital | OTHER |
| Massachusetts General Hospital | OTHER |
| National Institute on Drug Abuse (NIDA) |
Not provided
Not provided
Not provided
This study compares several different antiretroviral adherence measures, including digital pills, in HIV+ individuals who are maintained on opioid analgesics.
This study compares digital pills, electronic pill bottles, self-report, and dried blood spots, in measuring adherence to antiretroviral medications containing emtricitabine and tenofovir.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MyTPill | Participants receive digital pills for three months, have a 2-week washout, then switch to Wisepill. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MyTPill, a digital pill | Device | MyTPill is a digital pill containing an approved medication |
|
| Measure | Description | Time Frame |
|---|---|---|
| Dried blood spots | Measurement of dried blood spots for TDF/FTC concentrations | six months |
| Adherence per two different electronic adherence measures | Secondary outcomes are the identification of multi-level factors that are prevalent in the target population most closely linked to ART non-adherence and EAM non-adherence. | Six months |
| Measure | Description | Time Frame |
|---|---|---|
| Pill counts | Count numbers of antiretroviral pills at followup sessions | Six months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
HIV+
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Edward W Boyer, MD PhD | Ohio State University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Miami | Miami | Florida | 33136 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36627157 | Background | Bischof JJ, Chai P, Mohamed Y, Padappayil R, Merchant RC, Boyer EW, Rosen R, Reyes-Gibby CC, Viamonte M, W Carrico A. MyTPill: study protocol for a cross-over randomised controlled trial comparing novel strategies to monitor antiretroviral adherence among HIV+ prescription opioid users. BMJ Open. 2023 Jan 10;13(1):e062805. doi: 10.1136/bmjopen-2022-062805. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | May 29, 2026 | |
| Reset | Jun 24, 2026 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| May 29, 2026 | Jun 24, 2026 |
| NIH |
| Florida International University | OTHER |
Not provided
Not provided
Not provided